Epinephrine 0.15mg (1:2000); prefilled auto-injector; contains sulfites. Epinephrine acts on both alpha- and beta-adrenergic receptors. Through its action on alpha-adrenergic receptors ...

The EpiPen totally dominates the market. Either people don't know about the cheaper alternatives, or they do - but don't want to buy them. Business Insider looked at the number of prescriptions ...

(AP Photo/Rich Pedroncelli) (CN) — Pfizer Inc. has proposed to pay $345 million to settle litigation over price hikes of EpiPen, according to court documents filed Thursday. The drug manufacturer, ...

The furore over Mylan’s ‘price gouging’ in relation to EpiPen in the US went global, thanks to social media. Daniel Ghinn examines the reaction of healthcare professionals on social media ...

Jan 16 (Reuters) - Mylan has agreed to pay $73.5 million to settle a class action lawsuit by drug wholesalers accusing the drugmaker of scheming to overcharge them for EpiPen allergy treatment ...

The state also says the companies paid doctors to say a 2-pak of EpiPen is medically necessary, so that the companies could stop selling individual EpiPens. EpiPen is the name brand for an ...

“EpiPen is what the babysitter uses, it’s what grandparents know how to use ... “[Mylan] could not do this in a competitive market, because in a competitive market, no one has to buy EpiPens.” Baldock ...

Rokita alleges the price increases of EpiPen, an auto-injectable epinephrine used to treat severe allergic reactions, prevented other similar medications from going to market. The lawsuit ...

An EpiPen can be a lifesaving measure that allows ... but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not ...

It also accuses the companies of paying doctors to endorse a 2-pak of the EpiPen and claim it is medically necessary, allowing the companies to stop selling individual EpiPens.

“For people with severe allergies, immediate access to an EpiPen device can mean the difference ... requiring those in need to purchase the medication repeatedly.